IL-2 controls trafficking receptor gene expression and Th2 response for skin and lung inflammation

Clinical Immunology

Volumn 145, Issue 1, 2012, Pages 82-88

  Ju, Shyr Te ^a   Sharma, Rahul ^a   Gaskin, Felicia ^a   Fu, Shu Man ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Autoimmune diseases; ; Inflammation; MOI; Scurfy mice; ; Treg;

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE MUTATION; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKIN INFLAMMATION; TH1 CELL; TH2 CELL; TRAFFICKING RECEPTOR GENE;

ANIMALS; ANTIGENS, CD4; CELL MOVEMENT; CYTOKINES; GENE EXPRESSION; INTERLEUKIN-2; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; PNEUMONIA; RECEPTORS, CELL SURFACE; SKIN; TH1 CELLS; TH2 CELLS;

EID: 84865466813     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.07.015     Document Type: Review

References (19)

1. Sharma R., Fu S.M., Ju S.T. IL-2: a two-faced master regulator of autoimmunity. J. Autoimmun. 2011, 36:91-97.
2. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993, 75:253-261.
3. + T cells. Eur. J. Immunol. 1995, 25:3053-3059.
4. Zheng L., Sharma R., Gaskin F., Fu S.M., Ju S.T. A novel role of IL-2 in organ-specific autoimmune inflammation beyond regulatory T cell checkpoint: Both IL-2 Knockout and Fas mutation prolong lifespan of Scurfy mice but by different mechanisms. J. Immunol. 2007, 179:8035-8041.
5. Vang K.B., Yang J., Mahmud S.A., Burchill M.A., Vegoe A.L., Farrar M.A. IL-2, 7, and 15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. J. Immunol. 2008, 181:3285-3290.
6. Sharma R., Sharma P.R., Kim Y.-C., Leitinger N., Lee J.K., Fu S.M., Ju S.-T. IL-2-controlled expression of multiple T cell trafficking genes and Th2 cytokines in the regulatory T cell-deficient Scurfy mice: implication to multiorgan inflammation and control of skin and lung inflammation. J. Immunol. 2011, 186:1268-1278.
7. Sharma R., Sung S.-S.J., Gaskin F., Fu S.M., Ju S.-T. A novel function of IL-2: chemokine/chemoattractant/retention receptor genes induction in Th subsets for skin and lung inflammation. J. Autoimmun. 2012, 38:322-331.
8. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001, 27:68-73.
9. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.-L., Buist N., Levy-Lahad E., Mazzella M., Goulet O., Perroni L., Bricarelli F.D., Byrne G., McEuen M., Proll S., Appleby M., Brunkow M.E. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001, 27:18-20.
10. Lin W., Truong N., Grossman W.J., Haribhai D., Williams C.B., Wang J., Martin M.G., Chatila T.A. Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J. Allergy Clin. Immunol. 2005, 116:1106-1115.
11. Nanki T., Lipsky P.E. Lack of correlation between chemokine receptor and T(h)1/T(h)2 cytokine expression by individual memory T cells. Int. Immunol. 2000, 12:1659-1667.
12. Cote-Sierra J., Foucras G., Guo L., Chiodetti L., Young H.A., Hu-Li J., Zhu J., Paul W.E. Interleukin 2 plays a central role in Th2 differentiation. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3880-3885.
13. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986, 136:2348-2357.
14. Howard M., Paul W.E. Interleukins for B lymphocytes. Lymphokine Res. 1982, 1:1-4.
15. Mach F., Sauty A., Iarossi A.S., Sukhova G.K., Neote K., Libby P., Luster A.D. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J. Clin. Invest. 1999, 104:1041-1050.
16. Cole K.E., Strick C.A., Paradis T.J., Ogborne K.T., Loetscher M., Gladue R.P., Lin W., Boyd J.G., Moser B., Wood D.E., Sahagan B.G., Neote K. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 1998, 187:2009-2021.
17. Rivas M.N., Koh Y.T., Chen A., Nguyen A., Lee Y.H., Lawson G., Chatila T.A. MyD88 is critically involved in immune tolerance breakdown at environmental interfaces of Foxp3-deficient mice. J. Clin. Invest. 2012, 122:1933-1947.
18. Duroudier N.P., Tulah A.S., Sayers I. Leukotriene pathway genetics and pharmacogenetics in allergy. Allergy 2009, 64:823-839.
19. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997, 91:521-530.